rTMS theray in CFS/ME

Therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in the patients with chronic fatigue syndrome/myalgic encephalomyelitis - rTMS in CFS/ME

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1042240065

Enrollment

100

Registered

2024-08-01

Start date

2018-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myalgic encephalomyelitus Myalgic encephalomyelitus

Interventions

Noninvasive repetitive transcranial magnetic stimulation is delivered to the left dorsolateral prefrontal cortex and primary motor area in the brain of participants.

D050781

Repetitive transcranial magnetic stimulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with myalgic encephalomyelitus daignosed with ICC2011

Exclusion criteria

Exclusion criteria: Patients with serious complications Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Amelioration of fatigue, general malaise, post-exertional malaise, brain fog, and unrefreshing sleep	—

Secondary

Measure	Time frame
Amelioration of pain, muscle weakness, and orthostatic intolerance	—

Contacts

Public ContactKunihisa Miwa

Miwa Naika Clinic

info@miwa-naika.com+81-76-482-3014

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026